Nephros (NEPH) Net Income Growth (1y) (2011 - 2026)
Powered by 
Analysis
Nephros (NEPH) Net Income Growth (1y) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 178.01 Bn | 172.41 Bn | 7.27 Bn | -47.84% |
| 2 | Intuitive Surgical | 131.29 Bn | 126.08 Bn | 1.96 Bn | 23.94% |
| 3 | Medtronic | 116.38 Bn | 107.56 Bn | 6.34 Bn | 41.36% |
| 4 | Stryker | 106.01 Bn | 102.53 Bn | 4.50 Bn | 44.34% |
| 5 | Boston Scientific | 63.40 Bn | 62.86 Bn | 3.85 Bn | 13.84% |
| 6 | Edwards Lifesciences | 48.89 Bn | 44.64 Bn | 1.35 Bn | -27.18% |
| 7 | Alcon | 32.59 Bn | 31.13 Bn | 1.68 Bn | -141.44% |
| 8 | Dexcom | 31.84 Bn | 29.89 Bn | 830.00 Mn | 38.54% |
| 9 | Steris | 20.61 Bn | 20.13 Bn | 684.20 Mn | 12.92% |
| 10 | Nephros | 48.31 Mn | 43.62 Mn | 4.03 Mn | 405.06% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 405.06% |
| Mar 31, 2026 | -81.48% |
| Dec 31, 2025 | -131.04% |
| Sep 30, 2025 | 84.15% |
| Jun 30, 2025 | 182.01% |
| Mar 31, 2025 | 359.62% |
| Dec 31, 2024 | 143.65% |
| Sep 30, 2024 | 195.31% |
| Jun 30, 2024 | 31.52% |
| Mar 31, 2024 | 29.49% |
| Dec 31, 2023 | -1.96% |
| Sep 30, 2023 | 93.97% |
| Jun 30, 2023 | 65.10% |
| Mar 31, 2023 | 84.95% |
| Dec 31, 2022 | 21.57% |
| Sep 30, 2022 | -172.22% |
| Jun 30, 2022 | -7.47% |
| Mar 31, 2022 | -90.66% |
| Dec 31, 2021 | -42.68% |
| Sep 30, 2021 | -23.03% |